212 related articles for article (PubMed ID: 8622402)
1. Camptothecins: new enthusiasm for an old drug.
Rowe PM
Lancet; 1996 Mar; 347(9005):892. PubMed ID: 8622402
[No Abstract] [Full Text] [Related]
2. [Irinotecan in colorectal cancer].
Pozzo C; Cassano A; Barone C
Tumori; 2001; 87(1 Suppl 1):S49-50. PubMed ID: 11300023
[No Abstract] [Full Text] [Related]
3. FDA approves irinotecan as first-line therapy for colorectal cancer.
Oncology (Williston Park); 2000 May; 14(5):652, 654. PubMed ID: 10853457
[No Abstract] [Full Text] [Related]
4. [Therapeutic approach for colorectal cancer with topoisomerase as a molecular target].
Tsunoda T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():472-5. PubMed ID: 14574938
[No Abstract] [Full Text] [Related]
5. Colorectal cancer chemotherapy: irinotecan.
Rougier P; Mitry E
Semin Oncol; 2000 Oct; 27(5 Suppl 10):138-43. PubMed ID: 11049046
[No Abstract] [Full Text] [Related]
6. Topoisomerase-I inhibitors in the management of colon cancer.
Willson JK
Ann N Y Acad Sci; 1996 Dec; 803():256-63. PubMed ID: 8993519
[No Abstract] [Full Text] [Related]
7. CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activity.
Bleiberg H
Tumori; 1997; 83(1 Suppl):S85-6. PubMed ID: 9154078
[No Abstract] [Full Text] [Related]
8. Schedule-dependent efficacy of camptothecins in models of human cancer.
Houghton PJ; Stewart CF; Zamboni WC; Thompson J; Luo X; Danks MK; Houghton JA
Ann N Y Acad Sci; 1996 Dec; 803():188-201. PubMed ID: 8993512
[No Abstract] [Full Text] [Related]
9. Preclinical and clinical trials of topoisomerase inhibitors.
Saijo N
Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
[TBL] [Abstract][Full Text] [Related]
10. Experimental chemotherapeutic agents for the treatment of colorectal carcinoma.
O'Reilly S; Rowinsky EK
Hematol Oncol Clin North Am; 1997 Aug; 11(4):721-58. PubMed ID: 9257153
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials using irinotecan.
Houghton PJ; Santana VM
J Pediatr Hematol Oncol; 2002 Feb; 24(2):84-5. PubMed ID: 11990709
[No Abstract] [Full Text] [Related]
12. Irinotecan for colorectal cancer: a small step forward.
O'Connell MJ
Lancet; 1998 Oct; 352(9138):1402. PubMed ID: 9807982
[No Abstract] [Full Text] [Related]
13. [The other camptothecins: recent advances with camptothecin analogues other than irinotecan and topotecan].
Lavergne O; Bigg DC
Bull Cancer; 1998 Dec; Spec No():51-8. PubMed ID: 9932086
[TBL] [Abstract][Full Text] [Related]
14. [Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Terauchi F
Nihon Rinsho; 2004 Oct; 62 Suppl 10():175-8. PubMed ID: 15535228
[No Abstract] [Full Text] [Related]
15. The evolving role of irinotecan: a broad-spectrum chemotherapeutic agent. Introduction.
Ajani JA
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):17-8. PubMed ID: 11200142
[No Abstract] [Full Text] [Related]
16. CPT-11 (irinotecan) in the treatment of colorectal cancer.
Armand JP; Ducreux M; Mahjoubi M; Abigerges D; Bugat R; Chabot G; Herait P; de Forni M; Rougier P
Eur J Cancer; 1995; 31A(7-8):1283-7. PubMed ID: 7577037
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan hydrochloride.
Wilkinson K
Clin J Oncol Nurs; 2001; 5(4):179-80, 184. PubMed ID: 12690622
[No Abstract] [Full Text] [Related]
18. [Second-line irinotecan chemotherapy in the treatment of metastatic colorectal cancers: phase III trials].
Mitry E; Ducreux M; Rougier P
Bull Cancer; 1998 Dec; Spec No():38-42. PubMed ID: 9932083
[TBL] [Abstract][Full Text] [Related]
19. Preclinical and clinical development of camptothecins.
Costin D; Potmesil M
Adv Pharmacol; 1994; 29B():51-72. PubMed ID: 8996601
[No Abstract] [Full Text] [Related]
20. Topoisomerase-I inhibitors in gynecologic tumors.
Haluska P; Rubin E; Verschraegen CF
Hematol Oncol Clin North Am; 1999 Feb; 13(1):43-61, vii-viii. PubMed ID: 10080069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]